2 completed, 1 unknown. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Livedoid Vasculopathy: new trials by email Literature Review of Livedoid Vasculopathy trials Research Report on Livedoid Vasculopathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy Study of Gene Therapy Drug (Neovasculgen) to Treat Secondary Raynaud's Phenomenon Neovasculgen - Secondary Raynaud's Phenomenon | Phase 1 / Phase 2 | Unknown | Artgen Biotech | 30 | 2015-03-01 | 2015-02-05 |
| MQX-503 Applied to the Hand Versus Nitroglycerin Ointment Applied to the Chest: A Pharmacokinetic Comparison nitroglycerin 0.9 % (MXQ-503), Nitroglycerin ointment 2%, USP - Raynaud's Phenomenon | Phase 1 | Completed | MediQuest Therapeutics | 12 | 2009-02-01 | 2011-05-17 |
| Dose Response to Topical Glyceryl Trinitrate in Patients With Raynaud's Phenomenon placebo cream, Glyceryl Trinitrate - Raynaud's Phenomenon | Phase 1 | Completed | Procris Pharmaceuticals | 10 | 2008-06-01 | 2008-12-30 |
Raynaud Disease (3) · Scleroderma, Systemic (1)
Cardiovascular Diseases (3) · Embolism and Thrombosis (3) · Peripheral Vascular Diseases (3) · Skin Diseases (3) · Skin Diseases, Vascular (3) · Skin and Connective Tissue Diseases (3) · Thrombosis (3) · Vascular Diseases (3) · Connective Tissue Diseases (1)
Nitroglycerin (2)
Artgen Biotech (1) · MediQuest Therapeutics (1) · Procris Pharmaceuticals (1)
United States (2) · Russia (1)